Blue Sparrow’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Blue Sparrow's ARQT Position: Q3 2026 in Review
Blue Sparrow opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 486,700 shares worth $12.9M. The stake represents 0.15% of the portfolio and ranks #100 among its holdings.
294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Blue Sparrow held 486,700 shares of Arcutis Biotherapeutics worth $12.9M as of Q3 2026.
- Arcutis Biotherapeutics was a new Blue Sparrow position in Q3 2026.
- Arcutis Biotherapeutics made up 0.15% of Blue Sparrow's portfolio in Q3 2026, its #100 holding.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Blue Sparrow's 13F filing for Q3 2026, filed 16 Nov 2026.